explore -WSS

explore

author：explore 2025-09-28 20:32:02 - browse：46534

STAT

There’s nothing better than a beautiful spring day after a long, cold winter. But there’s nothing worse than having that day ruined by the sneezing, sniffling, and itching that come with seasonal allergies.

Scientists don’t actually completely understand why we get seasonal allergies. The best estimation is that they’re an immune response to toxins in the natural environment that pollen also happens to trigger. That immune response begins with the production of IgE antibodies to combat the pollen. The antibodies link up with mast cells, and together they’re a ticking time bomb. When more allergens come along, they activate all those horrible symptoms.

In the new episode of “Boddities,” we dive into how this response happens, and what you can do about it to ease the symptoms and enjoy the season.

Watch other “Boddities” episodes:

Related: Watch: Episode 6: What happens to the brain when we get scared?

Related: Watch: Episode 4: Why do our ears pop?

Related: Episode 5: Why do bright lights make us see spots?

Previous article： Psychedelics group wrestles with new pharma identity
Next article： In utero gene editing: an explainer

hotspot

entertainment

WSS

Surprise medical billing ban raises prices elsewhere

A solution to the after

A new drug could help frostbite victims avoid its ravages

A new nitrogen execution bill also undermines medical licensing

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

He's a Nobel laureate. Critics say he was misleading on Covid

focus

explore

Related: Watch: Episode 6: What happens to the brain when we get scared?

Related: Watch: Episode 4: Why do our ears pop?

Related: Episode 5: Why do bright lights make us see spots?

leisure time

How one medical school became remarkably diverse

With competition flaring, obesity drug hits goal in liver disease study

FDA approval of Sarepta Duchenne genetic therapy gives me hope

In utero gene editing: an explainer

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Hospitals are piloting generative AI tools as regulators play catch

Bright Health sells Medicare Advantage business to Molina

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Drug repurposing or repositioning? The language matters

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Wikipedia

Measles policy set amid Florida outbreak alarms vaccine proponents

As AI regulations shape up, health tech startups beg for clarity

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Weight loss drugs aren’t covered by Obamacare. That may change

STAT readers on older presidents, polypills, Medicare, and more

FDA warns medical device makers about rise in fabricated data

explore

hotspot

entertainment

knowledge